Priority Date: 03.06.16 (US 201662345662P)

USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER

  • Application ID: EP17731359
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Reitstötter Kinzebach & Partner GbR is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 225 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 03.06.2016 - Priority Date (US 201662345662P)
  • 07.12.2017 - Publication A1 (WO2017210637)
  • 10.04.2019 - Publication A1 (EP3464373)

IPC Classification